Huan Gu

Dr. Huan Gu


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
HGHuan Gu
Huan Gu
SLSang Won Lee
Sang Won Lee
JCJoseph Carnicelli
Joseph Carnicelli
Teng ZhangTeng Zhang
Teng Zhang
DRDacheng Ren
Dacheng Ren
Microbial biofilm formation on indwelling medical devices causes persistent infections that cannot be cured with conventional antibiotics. To address this unmet challenge, we engineer tunable active surface topographies with micron-sized pillars that can beat at a programmable frequency and force level in an electromagnetic field. Compared to the flat and static controls, active topographies with the optimized design prevent biofilm formation and remove established biofilms of uropathogenic Escherichia coli (UPEC), Pseudomonas aeruginosa, and Staphylococcus aureus, with up to 3.7 logs of biomass reduction. In addition, the detached biofilm cells are found sensitized to bactericidal antibiotics to the level comparable to exponential-phase planktonic cells. Based on these findings, a prototype catheter is engineered and found to remain clean for at least 30 days under the flow of artificial urine medium, while the control catheters are blocked by UPEC biofilms within 5 days.

13 June 2022 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
DPDipesh Dinanath Pednekar
Dipesh Dinanath Pednekar
MLMadison A. Liguori
Madison A. Liguori
CMCláudia N. H. Marques
Cláudia N. H. Marques
Teng ZhangTeng Zhang
Teng Zhang
NZNan Zhang
Nan Zhang
HGHuan Gu
Huan Gu

10 December 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
SRSweta Roy
Sweta Roy
ABAli Adem Bahar
Ali Adem Bahar
HGHuan Gu
Huan Gu
SNShikha Nangia
Shikha Nangia
KSKarin Sauer
Karin Sauer
DRDacheng Ren
Dacheng Ren
Persistent bacterial infections do not respond to current antibiotic treatments and thus present a great medical challenge. These conditions have been linked to the formation of dormant subpopulations of bacteria, known as persister cells, that are growth-arrested and highly tolerant to conventional antibiotics. Here, we report a new strategy of persister control and demonstrate that minocycline, an amphiphilic antibiotic that does not require active transport to penetrate bacterial membranes, is effective in killing Escherichia coli persister cells [by 70.8 ± 5.9% (0.53 log) at 100 μg/mL], while being ineffective in killing normal cells. Further mechanistic studies revealed that persister cells have reduced drug efflux and accumulate more minocycline than normal cells, leading to effective killing of this dormant subpopulation upon wake-up. Consistently, eravacycline, which also targets the ribosome but has a stronger binding affinity than minocycline, kills persister cells by 3 logs when treated at 100 μg/mL. In summary, the findings of this study reveal that while dormancy is a well-known cause of antibiotic tolerance, it also provides an Achilles’ heel for controlling persister cells by leveraging dormancy associated reduction of drug efflux.

2 July 2025 in ACS Applied Engineering Materials
Verified
Journal Article
Open access
KBKaitlyn Benes
Kaitlyn Benes
MLMadison Liguori
Madison Liguori
CVCody J. Velikaneye
Cody J. Velikaneye
SKSarah Kispert
Sarah Kispert
APAlexis Pishnyuk
Alexis Pishnyuk
HGHuan Gu
Huan Gu
The persistent environmental challenges posed by synthetic plastics, particularly petroleum-derived petropolymers, such as polyethylene (PE), polypropylene (PP), and polystyrene (PS), have intensified the need for innovative recycling methods. Traditional recycling techniques often rely on harsh conditions, raising environmental and economic concerns. Biofilm-mediated biodegradation has emerged as a promising alternative, operating under mild conditions such as room temperature, neutral pH, and atmospheric pressure. However, the interactions between biofilm-forming microorganisms and synthetic plastics and the roles of secreted enzymes in these processes remain incompletely understood. This review explores the current understanding of biofilm-mediated biodegradationbiodeterioration, biofragmentation, bioassimilation, and mineralizationand the biochemical and physical interactions that control these processes. We highlight the latest findings on the enhancement of petropolymer degradation by biofilms, focusing on the roles of oxidative and attachment enzymes and the environmental factors influencing degradation efficiency. Understanding these complex interactions can inform the design of next-generation enzyme-responsive polymers that are not only easier to degrade but can also serve as smart materials for diverse applications, such as antifouling coatings on metals. This perspective bridges critical knowledge gaps and provides insights into harnessing biofilm-mediated processes for sustainable material innovation.

4 March 2025 in Advanced Functional Materials
Verified
Journal Article
Open access
ZHZehui Han
Zehui Han
YXYikang Xu
Yikang Xu
HGHuan Gu
Huan Gu
Teng ZhangTeng Zhang
Teng Zhang
DRDacheng Ren
Dacheng Ren
In the innate immune system of mammalians, beating cilia of epithelial cells and the attached mucin proteins prevent the colonization of microbial pathogens. Abiotic biomaterials of medical implants lack such protection and thus are susceptible to microbial colonization, leading to biofilm formation and persistent infections with high‐level antibiotic tolerance. To address this challenge, the team further develops its new strategy of biofilm control by magnetically driven oscillation of micron‐sized pillars on biomaterials. This study is based on a bioinspired design by covalently coating the pillars with mucin, a glycoprotein found ubiquitously in mammalian innate immune systems. The results show that mucin coating significantly enhances the antifouling effects of active topography in both the inhibition of Pseudomonas aeruginosa biofilm formation and removal of its mature biofilms. Analysis using scanning electron microscopy (SEM) reveals that mucin coating inhibits bacterial attachment near the pillar base, the area protected from the direct force of beating pillars. In addition, mucin coating enhances the twitching motility of P. aeruginosa but represses its swarming motility and the synthesis of cyclic di‐GMP. These effects further contribute to the antifouling activities. Overall, these findings demonstrate the feasibility of engineering bioinspired antifouling materials for safer medical devices.

6 February 2012 in Parasitology
Verified
Journal Article
Closed access
PDF file
BCBo-Lin Chen
Bo-Lin Chen
GZGui-Ying Zhang
Gui-Ying Zhang
SWShi-Ping Wang
Shi-Ping Wang
QLQian Li
Qian Li
MXMei-Hua Xu
Mei-Hua Xu
YMYi-Bing Mu
Yi-Bing Mu
SUMMARY: The aim of this study was to evaluate the therapeutic effects of osteopontin neutralization treatment on schistosome-induced liver injury in BALB/C mice. We randomly divided 100 BALB/C mice into groups A, B, C, D and group E. Mice in all groups except group A were abdominally infected with schistosomal cercariae to induce a schistosomal hepatopathological model. Mice in group C, D and group E were respectively administered with praziquantel, praziquantel plus colchicine and praziquantel plus neutralizing osteopontin antibody. We extracted mouse liver tissues at 3 and 9 weeks after the ‘stool-eggs-positive’ day, observed liver histopathological changes by haematoxylin-eosin and Masson trichrome staining and detected the expression of osteopontin, alpha-smooth muscle actin (α-SMA) and transforming growth factor-beta (TGF-β1) by immunohistochemistry, RT-PCR and Western blot. We found that praziquantel plus neutralizing osteopontin antibody treatment significantly decreased the granuloma dimension, the percentage of collagen and the expression of osteopontin,α-SMA and TGF-β1 compared to praziquantel plus colchicine treatment in both the acute and chronic stage of schistosomal liver damage (P<0·05). So we believe that the combined regimen of osteopontin immunoneutralization and anti-helminthic treatment can reduce the granulomatous response and liver fibrosis during the schistosomal hepatopathologic course.